Mimedx (MDXG) Preferred Stock Liabilities (2020 - 2023)

Mimedx's Preferred Stock Liabilities history runs 4 years deep, the most recent figure standing at $92.5 million for Q3 2023.

• In Q3 2023, Preferred Stock Liabilities changed 0.0% year-over-year to $92.5 million; the TTM figure through Sep 2023 stood at $92.5 million (changed 0.0% YoY), while the FY2022 annual figure was $92.5 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities came in at $92.5 million for Q3 2023 at Mimedx, roughly flat from $92.5 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $92.5 million in Q2 2021 to a low of $91.1 million in Q3 2020.
• A 4-year average of $92.3 million and a median of $92.5 million in 2021 frame the typical range for Preferred Stock Liabilities.
• Across the five-year window, Preferred Stock Liabilities grew 1.52% in 2021 and changed 0.0% in 2022, its largest moves.
• Mimedx's Preferred Stock Liabilities stood at $91.6 million in 2020, then gained by 1.01% to $92.5 million in 2021, then changed by 0.0% to $92.5 million in 2022, then changed by 0.0% to $92.5 million in 2023.
• According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $92.5 million, $92.5 million, and $92.5 million for Q3 2023, Q2 2023, and Q1 2023 respectively.

Peer Comparison